Cargando…
Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metabolic two-step bioactivation for their pharmacological efficacy. In the first step, a thiolactone is formed, which is then converted by cytochrome P450-dependent oxidation via sulfenic acids to the act...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470877/ https://www.ncbi.nlm.nih.gov/pubmed/34575790 http://dx.doi.org/10.3390/jof7090752 |
_version_ | 1784574312554954752 |
---|---|
author | Kiebist, Jan Schmidtke, Kai-Uwe Schramm, Marina König, Rosalie Quint, Stephan Kohlmann, Johannes Zuhse, Ralf Ullrich, René Hofrichter, Martin Scheibner, Katrin |
author_facet | Kiebist, Jan Schmidtke, Kai-Uwe Schramm, Marina König, Rosalie Quint, Stephan Kohlmann, Johannes Zuhse, Ralf Ullrich, René Hofrichter, Martin Scheibner, Katrin |
author_sort | Kiebist, Jan |
collection | PubMed |
description | Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metabolic two-step bioactivation for their pharmacological efficacy. In the first step, a thiolactone is formed, which is then converted by cytochrome P450-dependent oxidation via sulfenic acids to the active thiol metabolites. These metabolites are the active compounds that inhibit the platelet P2Y(12) receptor and thereby prevent atherothrombotic events. Thus far, described biocatalytic and chemical synthesis approaches to obtain active thienopyridine metabolites are rather complex and suffer from low yields. In the present study, several unspecific peroxygenases (UPOs, EC 1.11.2.1) known to efficiently mimic P450 reactions in vitro—but requiring only hydroperoxide as oxidant—were tested for biocatalytic one-pot syntheses. In the course of the reaction optimization, various parameters such as pH and reductant, as well as organic solvent and amount were varied. The best results for the conversion of 1 mM thienopyridine were achieved using 2 U mL(−1) of a UPO from agaric fungus Marasmius rotula (MroUPO) in a phosphate-buffered system (pH 7) containing 5 mM ascorbate, 2 mM h(−1) H(2)O(2) and 20% acetone. The preparation of the active metabolite of clopidogrel was successful via a two-step oxidation with an overall yield of 25%. In the case of prasugrel, a cascade of porcine liver esterase (PLE) and MroUPO was applied, resulting in a yield of 44%. The two metabolites were isolated with high purity, and their structures were confirmed by MS and MS(2) spectrometry as well as NMR spectroscopy. The findings broaden the scope of UPO applications again and demonstrate that they can be effectively used for the selective synthesis of metabolites and late-state diversification of organic molecules, circumventing complex multistage chemical syntheses and providing sufficient material for structural elucidation, reference material, or cellular assays. |
format | Online Article Text |
id | pubmed-8470877 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84708772021-09-27 Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases Kiebist, Jan Schmidtke, Kai-Uwe Schramm, Marina König, Rosalie Quint, Stephan Kohlmann, Johannes Zuhse, Ralf Ullrich, René Hofrichter, Martin Scheibner, Katrin J Fungi (Basel) Article Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metabolic two-step bioactivation for their pharmacological efficacy. In the first step, a thiolactone is formed, which is then converted by cytochrome P450-dependent oxidation via sulfenic acids to the active thiol metabolites. These metabolites are the active compounds that inhibit the platelet P2Y(12) receptor and thereby prevent atherothrombotic events. Thus far, described biocatalytic and chemical synthesis approaches to obtain active thienopyridine metabolites are rather complex and suffer from low yields. In the present study, several unspecific peroxygenases (UPOs, EC 1.11.2.1) known to efficiently mimic P450 reactions in vitro—but requiring only hydroperoxide as oxidant—were tested for biocatalytic one-pot syntheses. In the course of the reaction optimization, various parameters such as pH and reductant, as well as organic solvent and amount were varied. The best results for the conversion of 1 mM thienopyridine were achieved using 2 U mL(−1) of a UPO from agaric fungus Marasmius rotula (MroUPO) in a phosphate-buffered system (pH 7) containing 5 mM ascorbate, 2 mM h(−1) H(2)O(2) and 20% acetone. The preparation of the active metabolite of clopidogrel was successful via a two-step oxidation with an overall yield of 25%. In the case of prasugrel, a cascade of porcine liver esterase (PLE) and MroUPO was applied, resulting in a yield of 44%. The two metabolites were isolated with high purity, and their structures were confirmed by MS and MS(2) spectrometry as well as NMR spectroscopy. The findings broaden the scope of UPO applications again and demonstrate that they can be effectively used for the selective synthesis of metabolites and late-state diversification of organic molecules, circumventing complex multistage chemical syntheses and providing sufficient material for structural elucidation, reference material, or cellular assays. MDPI 2021-09-13 /pmc/articles/PMC8470877/ /pubmed/34575790 http://dx.doi.org/10.3390/jof7090752 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kiebist, Jan Schmidtke, Kai-Uwe Schramm, Marina König, Rosalie Quint, Stephan Kohlmann, Johannes Zuhse, Ralf Ullrich, René Hofrichter, Martin Scheibner, Katrin Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases |
title | Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases |
title_full | Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases |
title_fullStr | Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases |
title_full_unstemmed | Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases |
title_short | Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases |
title_sort | biocatalytic syntheses of antiplatelet metabolites of the thienopyridines clopidogrel and prasugrel using fungal peroxygenases |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470877/ https://www.ncbi.nlm.nih.gov/pubmed/34575790 http://dx.doi.org/10.3390/jof7090752 |
work_keys_str_mv | AT kiebistjan biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases AT schmidtkekaiuwe biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases AT schrammmarina biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases AT konigrosalie biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases AT quintstephan biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases AT kohlmannjohannes biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases AT zuhseralf biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases AT ullrichrene biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases AT hofrichtermartin biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases AT scheibnerkatrin biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases |